Professor, GU Medical Oncologist interested in #immunotherapy #cancerresarch #ProstateCancer @SylvesterCancer @umiamihealth. All views are my own.
Miami, FL
Joined April 2009
- Tweets341
- Following755
- Followers803
- Likes763
Pinned Tweet
I'm excited to start a new chapter
Let's give Dr. Marijo Bilusic a warm welcome this morning! @mbilusic recently joined #SylvesterCancer as Leader of the Genitourinary Cancers Site Disease Group and will hold clinic sessions in #Miami. Read more: physician-news.umiamihealth.… #NCI #NIH
Marijo Bilusic, MD, PhD retweeted
Encouraging OS results in neuroendocrine prostate cancer at #ESMO26!
#KEYNOTE-365 evaluated pembrolizumab + carboplatin/etoposide vs chemotherapy alone.
• mOS: 10.2 vs 7.1 months (HR 0.33)
• rPFS: 5.1 vs 4.0 months (HR 0.66)
• PD-L1 CPS ≥1: mOS 11.0 vs 4.8 months (HR 0.16)
No new safety signals observed.
@myESMO @oncoalert
Join me for the 2026 ESMO USA East Conference! Register for free today at totalhealthoncology.com/upco… cvent.me/k8k3vK?sms=2&cn=f73… #totalhealth ESMO oncology
Marijo Bilusic, MD, PhD retweeted
Could a lower dose of cancer treatment mean fewer side effects without compromising effectiveness?
Sylvester’s Dr. Marijo Bilusic (@mbilusic) spoke with @OncNewsCentral about research suggesting lower starting doses of enfortumab vedotin may reduce severe side effects in older bladder cancer patients.
spr.ly/6019BHENGU
Marijo Bilusic, MD, PhD retweeted
Inspiring CEO address from Gina Carithers #PCFRetreat26: "Same mission. Greater momentum. Research at our core. Patients at the center."👉@PCF_News is turning science into access for patients and veterans. 💙 @PCF_Science @urotoday @AndreaMiyahira @PhillipKooMD
Prostate Cancer: Leading Oncologists Say Treatment Is Shifting Beyond a One-Size-Fits-All Approach Toward More Personalized Care survivornet.com/articles/pro…
Marijo Bilusic, MD, PhD retweeted
Today, we’re launching an initiative we’re calling #YourNCI that highlights how valuable the public investment in cancer research is – and how it pays off in cancer prevention, screening, diagnosis, survivorship and better, more effective treatments.
Diabetes Drug May Echo the Metabolic Benefits of Exercise in Prostate Cancer Care📚
The anti-obesogenic metabolite, Lac-Phe, is elevated by metformin treatment in prostate cancer patients
link.springer.com/article/10…
@SN and #SNAuthor.
Marijo Bilusic, MD, PhD retweeted
Welcome to Miami - where the chance of nature killing you while walking to work is definitely higher than zero!
Marijo Bilusic, MD, PhD retweeted
National Cancer Institute's Working Group on Biochemically Recurrent Prostate Cancer: Clinical Trial Design Considerations
@theNCI
#BCR #ProstateCancer #ClinicalTrial
ascopubs.org/doi/10.1200/JCO…
Marijo Bilusic, MD, PhD retweeted
For those out there with less gray hair than me…
Never underestimate the value in working with good people towards a common goal.
You can always do more together
Sometimes academia makes us forget that science is a team sport & no one does anything alone
#ESMO25 @myESMO
This ongoing trial is part of an organic collaboration of investigators & @theNCI seeking knowledge re: #PSMA+ #BCR
@HelenMoonMD @laurasenamd @Dr_JeannyAC @EdwinPosadasMD @RPachynski @CathyHandy @CPDR_Labs @mbilusic @melissaabel20 @FatimaKarzai & others
#ESMO25
Marijo Bilusic, MD, PhD retweeted
🔔Join us this morning at the virtual @SylvesterCancer 2025 #ClinicalTrialsCourse I will be speaking on importance of #communityengagement and addressing population needs when designing a trial.
🎯If your trial does not enroll the target population , it won’t succeed.
👉🏽Sign up here: sylvesterctc.vfairs.com/
Marijo Bilusic, MD, PhD retweeted
Vitamin B12 for prophylaxis of capecitabine-associated hand–foot syndrome
💥Oral methylcobalamin reduced capecitabine-related HFS in HER2-negative early BC, with no added safety concerns
💬A simple prophylaxis option to support treatment adherence
bmj.com/content/390/bmj-2025…
Marijo Bilusic, MD, PhD retweeted
We had the honor of inviting Sylvester patient Donica Stephens to join us at the @Marlins Prostate Cancer Awareness Game. 🙌
Donica first met with Dr. Sanoj Punnen (@sanojpunnen) at the @dsui_miami_uro, part of @UMiamiHealth, and was later referred to Sylvester medical oncologist Dr. Marijo Bilusic (@mbilusic) to continue his cancer care. 🧡
Marijo Bilusic, MD, PhD retweeted
#Metformin study reveals weight management benefits for ADT therapy. @Silke_Gillessen and @neerajaiims discuss the results of the #STAMPEDE trial's metformin arm. The phase 3 trial evaluates the addition of metformin to ADT in patients with #mHSPC. #FullVideo on UroToday > bit.ly/4frHqvg
Hot off the press...
Overcoming common emerging barriers to effective neoadjuvant immunotherapies: Expert Review of Anticancer Therapy: Vol 0 , No ja - Get Access tandfonline.com/doi/full/10.…
Marijo Bilusic, MD, PhD retweeted
Abs#45 @asco #GU25
Prelim data shows near term metastatic progression (conventional imaging) is a rare event in #PSMA+ #BCR #ProstateCancer
Are we overtreating pts w/ median age of 70+ based on lack of understanding of #PSMA?
This study continues…
meetings.asco.org/abstracts-…
Marijo Bilusic, MD, PhD retweeted
“Truqap combination (w/abiraterone) in #PTEN -deficient #mCSPC #ProstateCancer demonstrated statistically significant & clinically meaningful improvement in rPFS in #CAPItello-281 Phase III trial”
Look forward to seeing this data & relative toxicity astrazeneca.com/media-centre…